NCT04023903View on ClinicalTrials.gov

A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

April 4, 2019

Primary Completion Date

June 14, 2019

Study Completion Date

June 14, 2019

Conditions
Healthy Subject
Interventions
DRUG

Bardoxolone methyl

Bardoxolone methyl 5 mg capsules

DRUG

Bardoxolone methyl

Bardoxolone methyl 5 mg capsules

Trial Locations (1)

532-0003

Medical Corporation Heishinkai OPHAC Hospital, Osaka

All Listed Sponsors
lead

Kyowa Kirin Co., Ltd.

INDUSTRY

NCT04023903 - A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults | Biotech Hunter | Biotech Hunter